Clinical Trial Update: A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical photodynamic therapy with 5-aminolevulinic acid for actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE)

Snippet

Sponsor: Biofrontera Bioscience GmbH | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED